Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 34, Issue 3, 2016, Pages 184-187

  Llorca Otero, Laura ^a   Girón Moreno, Rosa ^a   Buendía Moreno, Buenaventura ^a   Valenzuela, Claudia ^a   Guiu Martínez, Alba ^a   Alarcón Cavero, Teresa ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Achromobacter xylosoxidans; Cystic fibrosis; Lung function

Indexed keywords

IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

ACHROMOBACTER XYLOSOXIDANS; ACHROMOBACTER XYLOSOXIDANS INFECTION; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; EXPIRATORY RESERVE VOLUME; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAM NEGATIVE INFECTION; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; RETROSPECTIVE STUDY; SPAIN; SPUTUM CULTURE; ACHROMOBACTER DENITRIFICANS; ADOLESCENT; COMPLICATION; CYSTIC FIBROSIS; GRAM-NEGATIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; YOUNG ADULT;

ACHROMOBACTER DENITRIFICANS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84960113792     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2015.05.006     Document Type: Article

References (30)

1. O. Ciofu, C.R. Hansen, and N. Høiby Respiratory bacterial infections in cystic fibrosis Curr Opin Pulm Med 19 2013 251 258
2. M. Hogardt, J. Ulrich, H. Riehn-Kopp, and B. Tümmler EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates J Clin Microbiol 47 2009 3435 3438
3. T.J. Kidd, K.A. Ramsay, H. Hu, P.T.P. Bye, M.R. Elkins, K. Grimwood, and et al. Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients J Clin Microbiol 47 2009 1503 1509
4. F. De Baets, P. Schelstraete, S. Van Daele, F. Haerynck, and M. Vaneechoutte Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance J Cyst Fibros 6 2007 75 78
5. J.M. Duggan, S.J. Goldstein, C.E. Chenoweth, C.A. Kauffman, and S.F. Bradley Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature Clin Infect Dis 23 1996 569 576
6. L. Amoureux, J. Bador, S. Fardeheb, C. Mabille, C. Couchot, C. Massip, and et al. Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates Appl Environ Microbiol 79 2013 7142 7149
7. R. Manfredi, A. Nanetti, M. Ferri, and F. Chiodo Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus Eur J Clin Microbiol Infect Dis 16 1997 933 938
8. Y.H. Lin, P.Y. Liu, Z.Y. Shi, Y.J. Lau, and B.S. Hu Comparison of polymerase chain reaction and pulsed-field gel electrophoresis for the epidemiological typing of Alcaligenes xylosoxidans subsp. xylosoxidans in a burn unit Diagn Microbiol Infect Dis 28 1997 173 178
9. U.S. CF Foundation, Patient Registry 1995, 1996, 1997, 1999, 2001, 2002, 2010, 2011 Annual Report. Bethesda, Maryland.
10. H. Peltroche-Llacshuanga, H. Kentrup, and G. Haase Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis Eur J Clin Microbiol Infect Dis 17 1998 132 134
11. V.B. Rudkjøbing, T.R. Thomsen, M. Alhede, K.N. Kragh, P.H. Nielsen, U.R. Johansen, and et al. True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis J Clin Microbiol 49 2011 4352 4355
12. K. Tan, S.P. Conway, K.G. Brownlee, C. Etherington, and D.G. Peckham Alcaligenes infection in cystic fibrosis Pediatr Pulmonol 34 2002 101 104
13. L. Amoureux, J. Bador, E. Siebor, N. Taillefumier, A. Fanton, and C. Neuwirth Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: first French data J Cyst Fibros 12 2012 170 176
14. W.M. Dunne, and S. Maisch Epidemiological investigation of infections due to Alcaligenes species in children and patients with cystic fibrosis: use of repetitive-element-sequence polymerase chain reaction Clin Infect Dis 20 1995 836 841
15. R.H.V. Pereira, A.P. Carvalho-Assef, R.M. Albano, T.W. Folescu, M.C.M.F. Jones, R.S. Leão, and et al. Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients J Clin Microbiol 49 2011 3649 3651
16. A. McGregor, F. Schio, S. Beaton, V. Boulton, M. Perman, and G. Gilbert The MicroScan WalkAway diagnostic microbiology system - an evaluation Pathology 27 1995 172 176
17. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. CLSI document M100-S23 2013 Clinical and Laboratory Standards Institute Wayne, PA
18. J.L. Burns, J. Emerson, J.R. Stapp, D.L. Yim, J. Krzewinski, L. Louden, and et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States Clin Infect Dis 27 1998 158 163
19. H. Vu-Thien, D. Moissenet, M. Valcin, C. Dulot, G. Tournier, and A. Garbarg-Chenon Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center Eur J Clin Microbiol Infect Dis 15 1996 876 879
20. W. Ridderberg, K.E.M. Bendstrup, H.V. Olesen, S. Jensen-Fangel, and N. Nørskov-Lauritsen Marked increase in incidence of Achromobacter xylosoxidans infections caused by sporadic acquisition from the environment J Cyst Fibros 10 2011 466 469
21. A. Lambiase, M.R. Catania, M. Del Pezzo, F. Rossano, V. Terlizzi, A. Sepe, and et al. Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients Eur J Clin Microbiol Infect Dis 30 2011 973 980
22. N. Wellinghausen, J. Ko, B. Wirths, A. Sigge, and S. Poppert Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis J Clin Microbiol 43 2005 4070 4075
23. A. Fernández-Olmos, M. García-Castillo, M.-I. Morosini, A. Lamas, L. Máiz, and R. Cantón MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients J Cyst Fibros 11 2012 59 62
24. N. Degand, E. Carbonnelle, B. Dauphin, J.-L. Beretti, M. Le Bourgeois, I. Sermet-Gaudelus, and et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting Gram-negative bacilli isolated from cystic fibrosis patients J Clin Microbiol 46 2008 3361 3367
25. T.H. Jakobsen, M.A. Hansen, Jensen Pe, L. Hansen, L. Riber, A. Cockburn, and et al. Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes PLOS ONE 8 2013 e68484
26. C. Rønne Hansen, T. Pressler, N. Høiby, and M. Gormsen Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study J Cyst Fibros 5 2006 245 251
27. L. Barrado, P. Brañas, Orellana MÁ, M.T. Martínez, G. García, J.R. Otero, and et al. Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain J Clin Microbiol 51 2013 1927 1930
28. G. Taccetti, S. Campana, F. Festini, M. Mascherini, and G. Döring Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients Eur Respir J 26 2005 458 461
29. C.R. Hansen, T. Pressler, K.G. Nielsen, P.e. Jensen, T. Bjarnsholt, and N. Høiby Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients J Cyst Fibros 9 2010 51 58
30. M. Wang, W. Ridderberg, C.R. Hansen, N. Høiby, S. Jensen-Fangel, H.V. Olesen, and et al. Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis J Cyst Fibros 12 2013 638 643